Monkey circulating immune complex(CIC)ELISA Kit

Monkey circulating immune complex(CIC)ELISA Kit

Product Details

Customer Reviews and Q&A

Product Details

Related Products

Customer Reviews and Q&A

Home
Kit
ELISA Kits
Monkey circulating immune complex(CIC)ELISA Kit

Protocol MSDS

Code	CSB-E15098Mk
Size	96T,5×96T,10×96T
Price	Request a Quote
Trial Size	24T ELISA Kit Trial Size (Only USD$150/ kit) * Sample kit cost can be deducted as a $30 credit for each 96-assay kit of the same analyte and brand you subsequently purchase within six months until depleted. More details >> Interested in a trial size? Please leave a message below.
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Related Products
Customer Reviews and Q&A

Target Name

circulating immune complex(CIC)

Abbreviation

CIC

Species

Monkey

Sample Types

serum, plasma

Detection Range

0.312 μg/mL-20 μg/mL

Sensitivity

0.078 μg/mL

Assay Time

1-5h

Sample Loading Volume

50-100ul

Detection Wavelength

450 nm

Research Area

Others

Assay Principle

quantitative

Measurement

Sandwich

Precision

Typical Data

These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

µg/ml	OD1	OD2	Average	Corrected
20	1.999	2.097	2.048	1.901
10	1.654	1.746	1.700	1.553
5	1.122	1.142	1.132	0.985
2.5	0.543	0.555	0.549	0.402
1.25	0.337	0.345	0.341	0.194
0.625	0.237	0.245	0.241	0.094
0.312	0.193	0.196	0.195	0.048
0	0.146	0.148	0.147

ELISA Data Analysis

ELISA Standard Curve & Curve Expert software

Troubleshooting
and FAQs

ELISA kit FAQs

Storage

Store at 2-8°C. Please refer to protocol.

Shelf Life

6 months

Lead Time

3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx.

Description

This Monkey CIC ELISA Kit was designed for the quantitative measurement of Monkey CIC protein in serum, plasma. It is a Sandwich ELISA kit, its detection range is 0.312 μg/mL-20 μg/mL and the sensitivity is 0.078 μg/mL .

■ Customer Reviews

Average Rating:

5.0 - 4 reviews

Submit a Review here

Sample type: Serum

Sample species: Monkey

Review: The difference between the kit batches is small, and the test repeatability is better!

By Anonymous

Sample type: Serum

Sample species: Monkey

Sample dilution: No dilution

Review: I used the monkey CIC enzyme-linked immunosorbent assay kit to detect monkey serum, and the results were good. The standard curve was fitted with four parameters, the coefficient of determination was greater than 0.99, the accuracy of each point on the standard curve was between 80-120%, and the difference between duplicate wells was less than 15%.

By Anonymous

Sample type: Serum

Sample species: Monkey

Sample dilution: No dilution

Review: I used the monkey CIC enzyme-linked immunosorbent assay kit to detect monkey serum, and the results were good. The standard curve was fitted with a four-parameter model, the coefficient of determination was greater than 0.99, the accuracy of each point on the standard curve was between 80-120%, and the difference between duplicate wells was less than 15%.

By Anonymous

Sample type: Serum

Sample species: Monkey

Sample dilution: No dilution

By Anonymous

Read more reviews >>

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

GPC3: The Next-Promising Target in Cancer Immunotherapy TNFRSF9: A Potent Immune-Stimulator in Cancer TNFR1: Elucidating Dual Mechanisms and Evolving as a Precision Therapeutic Target NRG1: an Intriguing Therapeutic Target in Diseases NKG2D, a Powerful Molecule Involved In CAR-T And Car-NK Cell Therapy DLL3: A New Molecular Target in Cancer Chemokine Receptor CCR4: the Key Role of CCR4+Treg Cells in Cancer Immunotherapy CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! TPBG/5T4: the Oncofetal Protein, an Appealing Target for ADC or Vaccine Therapeutics in Tumors! Twice Halted in One Year! Is Akeso's CD73 Monoclonal Antibody in Jeopardy Again? Is PD-1's Golden Partner Still Worth It? GFRAL: A Promising Metabolic Target for Improving Obesity and Anorexia/Cachexia 63.9% Objective Response Rate! B7-H3 Targeted Therapy Transforms Small Cell Lung Cancer Treatment, Domestic Players Compete in Hundred-Billion-Yuan Market SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! Exploring Neurodegeneration: A Comprehensive Guide for Researchers GIPR: the Crucial Regulator of Glucose and Lipid Metabolism in Diabetes and Obesity! What Are the Effects of Abnormalities in the ALK Gene Introduction of Hepatocellular Carcinoma Related Signaling Pathways Mesothelin: A Rising Star of Cancer Immunotherapy ACE2, The Hottest Target of SARS-CoV-2 Invasion GLP-1R: An Energy Metabolism Regulator of GPCR Family, an Effective Drug Target for Type 2 Diabetes Therapy! TM4SF1: a Member of the Transmembrane-4-Superfamily (L6), a New Vascular Therapeutic Target? LY6G6D (LY6-G): A New Member of Lymphocyte Antigen-6 Family Holds Big Opportunities in Bispecific Antibody for CRC Treatment! Serotransferrin/TF: a Major Transferrin in Plasma, a Novel TF-Modified Nanoparticle for Tumor-Targeting Research! Cadherin-17 (CDH17): A Viable Target in Bispecific Antibodies or CAR-T Therapy to Fight Many Gastrointestinal Cancers! Tumor Necrosis Factor (TNF) The Overview of Breast Cancer: Related Signaling Pathways, Therapeutic Targets CDCP1: A Key Mediator for Cell Signaling in Cancers, an Emerging Target for Anti-Tumor Drugs! The "Plaque Cleaner" in Blood Vessels Has Arrived! CD25+ Regulatory T Cells Transform into CAR-Tregs with Amazing Results The Review of Post-translational Modifications ENPP3 (CD203c): An Extracellular Enzyme, a Regulator for Nucleotide and Energy, an Indicator for Allergies, an Effective Target for RCC Therapy! Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies? DSG3: An Emerging Tumor-Associated Adhesion Factor, a Specific Marker for the Clinical Diagnosis of Pemphigus Vulgaris (PV)! Targeting LRRC15: From tumor microenvironment regulation to fibrotic/infectious disease therapy IL-6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research! T Cell Activation - The Switch for T Cell Executive Function Major Start to 2026: Impressive Clinical Data for CDH6-Targeting ADC, with Domestic Follow-Ups Close Behind TNFSF15/TL1A: The Rise of the Next Billion-Dollar Target as Pharma Giants Stake Their Claims The Structure, Function, and Research Progress of Lymphotoxin β Receptor (LTBR) in Disease and Drug Development TNFRSF13C (BAFF-R): A Key Target for Immune Regulation and Disease Treatment DLL4: A Key Target for Angiogenesis Regulation IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion CCL17: A Chemokine with Multiple Biological Functions Immune Battlefield's "Scout": Decoding the NCR3 Target PTH1R: Key Therapeutic Target in Bone & Metabolic Health B7-H6: A Key Ligand of NK Cell Immune Checkpoints Reshaping the Landscape of Tumor Immunotherapy MICB: a key molecule that bridges cellular stress and immune responses LYPD3: An Emerging Star in Solid Tumor Therapy Parathyroid Hormone (PTH): A Key Target for Regulating Calcium-Phosphate Metabolism and Skeletal Health SEZ6: A New Therapeutic Target for Neuroendocrine Tumors with Multiple ADCs in Clinical Development The Metabolic Achilles' Heel of Cancer Stem Cells: New Mechanism of LGR5 Reveals Metformin's Anticancer Potential Targeting TNFRSF13B: Dual-Target Strategies Usher in New Focus for Treating Tumors and Autoimmune Diseases IL1RAP: Background, Research Mechanisms, Signaling Pathways, Related Diseases, and Latest Advances in Drug Development Groundbreaking! "Cancer Immunol Res": mRNA-LNP Targeting FAP Reprograms T Cells In Vivo, Outperforming Traditional CAR-T in Pancreatic Cancer BTLA: An Emerging Target in Immunotherapy – New Insights into Cancer and Autoimmune Diseases The Multifaceted World of ADAM9: Beyond Proteolytic Function Beyond PD-1? The Potential and Breakthroughs of the Emerging Immune Checkpoint BTLA CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug Development ELISA Data Analysis How to Do The Pre-experiment before Your ELISA Experiment Four Types of ELISA 11 tips for choosing your right ELISA kit Do you Often Trouble in These Problems of ELISA? Problems and Solutions in ELISA Experiments

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Message

Product >> Product Name：
Product >> Code：
Name： *
Email： *
Company/Organization：
Phone：
Since emails may get flagged by spam filters occasionally, we recommend leaving your phone number as a precaution. Your information is safe with us.
Question/Comment： *
Your Region： *
I'd like to receive email newsletters from Cusabio

Yes

No
How do you know CUSABIO?

Email

Distributor

Search engine

Advertisement

Others
CAPTCHA verification：
Please enter the characters shown. Click the image to refresh if unclear.

Intra-assay Precision (Precision within an assay): CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess.

Inter-assay Precision (Precision between assays): CV%<10%

Three samples of known concentration were tested in twenty assays to assess.